Sales Contact

T: +33 1 8362 9036
Email

Industry Publications

"Long Term Care for the Elderly in France, European Comparison", 2011

Industry Report published by Candesic, Deomenos and Epsilon Research

Click here for preview

 

> Order an Epsilon Market Report (starting at €950) > mail

NB: includes access to the underlying EMAT reports

Alert on Reports Published
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe

Follow the sector on Twitter

Epsilon Research covers the M&A transactions for the "Health, Pharmaceuticals & Biotechnology" industry [1067 EMAT Reports], which includes:

 

Our analysts publish transaction multiples reports for private company M&A deals (announced 2004 onwards).

Each report presents detailed information on the deal value, structure and rationale, the target's activity, history and financial information; it includes the calculation of the key historic and current multiples: enterprise value over sales (EV/S), EBITDA (EV/EBITDA), or EBIT (EV/EBIT), P/E and Price to Book. All information sources are systematically given and company financials are carefully verified and restated if needed.

 

The reports are a unique source of information to have a comparable metric for the valuation of a private company, establish the "market value" of an investment or private equity investment portfolios.

 

The deal reports are published in Epsilon's EMAT database.
For an example of EMAT report, please click on this link.
If you wish to buy an EMAT Report, and you are not a customer, please contact us.

 

Recent M&A Deal Reports Published on EMAT

Date Acquirer Target Country Industries Valuation multiples See details
20/12/2022 Fielmann Medop | Ibervision Servicios Opticos | Elaboria Spain Specialised R&W, Medical Supplies, Eyewear (retail) * 111182
07/10/2022 Evergreen Healthcare Castlebridge Manor Nursing Home Ireland Care Home * 111002
08/09/2022 DCC Medi-Globe Technologies Germany Medical Supplies ** 109928
06/09/2022 ADDvise Group CliniChain Netherlands Medical Equipment ** 109947
30/08/2022 Neurocrine Biosciences Diurnal Group Wales Biotechnology, Biomedical Research Laboratory *** 109861
08/08/2022 Azenta B Medical Systems Luxembourg Medical Equipment *** 109985
03/07/2022 Private Group led by Adagia Minlay Paris Medical Implants or Prostheses Manufacturers * 109372
29/06/2022 FMC BioPhero Denmark Biotechnology, Fertilizers & Pesticides - Manufacturers ** 110528
07/06/2022 Azenta Barkey Germany Medical Equipment * 110012
27/04/2022 Getinge Fluoptics Isère Medical Equipment, Biotechnology ** 108896
14/03/2022 Eurazeo Horus Pharma Alpes-Maritimes Pharmaceuticals, Food Complements *** 109015
31/01/2022 Private group led by Turenne Santé and BNP Paribas Développement HAC Pharma France Biomedical Research Laboratory *** 109042
10/12/2021 Private gourp led by Capza Winback Group Pyrénées-Atlantiques Medical Equipment *** 107327
09/12/2021 Medicover NIPD Genetics Cyprus Laboratory Testing Services * 107245
03/12/2021 Recordati Eusa Pharma (UK) England Biomedical Research Laboratory ** 109851
02/12/2021 Private group led by PAI Partners SAS, Ontario Teachers’ Pension Plan Board Veonet Germany Clinics and hospitals ** 111277
30/11/2021 Emera Exploitations Mediaustral Reunion France Care Home * 109764
29/11/2021 DomusVi Le Tilleul Yvelines Care Home ** 109721
25/11/2021 Medios NewCo Pharma Group Germany Pharmaceuticals ** 109809
23/11/2021 Donaldson Comapany Solaris Biotechnology Italy Medical Equipment, Industrial Machinery for the Food Processing Industry ** 107305
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Database
Epsilon Multiple Analysis Tool
The Reference Source for Private Company Acquisition Multiples

Test & Subscribe
EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report